Health

Radnor, Pennsylvania–(Newsfile Corp. – October 5, 2021) – The law firm of Kessler Topaz Meltzer & Check, LLP reminds Annovis Bio, Inc. (NYSE American: ANVS) (“Annovis”) investors that a securities fraud class action lawsuit has more...

Henry Schein, Inc. HSIC is well positioned to gain from its extensive global foothold and diverse channel mix. However, escalating costs and expenses are putting pressure on the bottom line. Henry Schein currently carries a more...

Haemonetics Corporation HAE has been witnessing strong recovery in Plasma and Hemostasis Management units globally. However, the pandemic-led business disruptions in the Blood Center arm are concerning. The stock currently carries a Zacks Rank #3 (Hold). more...

Veteran Drug Developer Stephen Barat, Ph.D. Joins to Head Company’s Therapeutics Division TUCSON, Ariz., Oct. 05, 2021 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its more...

Data Shows Statistically Significant Improvements in Speed and Motor Function in PD Patients Annovis Bio to Request Meeting with FDA on Next Steps in Clinical Development Investor Conference Call to be Hosted Tuesday, October 5th, more...

NEW ORLEANS, Oct. 04, 2021 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: Annovis Bio, Inc. (ANVS) Class Period: 5/21/2021 – 7/28/2021 more...

BILLERICA, Mass., Oct. 04, 2021 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the third quarter ended September 30, 2021 after the market closes on November more...

Contract awarded for products that potentially bring improvement to health care industry CARLSBAD, Calif., Oct. 04, 2021 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE) announced its 7D FLASH Navigation System has received an Innovative Technology more...

Advances Development of Diagnostics for Sepsis-Causing Pathogens, Antibiotic Resistance, and Biothreat Pathogens LEXINGTON, Mass., Oct. 04, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that more...